clinical trial · NCT07725497
A Study of Luspatercept in People With Anemia
AnemiaChronic Kidney DiseaseLuspatercept
brief summary
The researchers are doing this study to test whether luspatercept works to improve hemoglobin levels in people with anemia caused by chronic kidney disease (CKD). The researchers will also test whether luspatercept is a safe treatment that causes few or mild side effects in participants.
started
Jul 20, 2026
primary completion
Jul 1, 2029
completion
Jul 1, 2029
last updated
Oct 13, 2026
official title
A Multicenter Phase 2 Study of Luspatercept in Patients With Anemia Due to Chronic Kidney Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol